Accredo Pharma Science Private Limited

Accredo Pharma Science Private Limited - pharma in Chennai, Tamil Nadu, India. FY 2026 financials & compliance.
CIN U74900TN2011PLC083825 Incorporated 30 December 2011 ROC Chennai HQ Chennai, Tamil Nadu, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹43.12 Cr
▲ 6% YoY
Net profit · FY 2025
₹1.44 Cr
Net margin 3.3%
EBITDA · FY 2025
₹4.43 Cr
EBITDA margin 10.3%
Authorised capital
₹11 Cr
Registered with MCA
Paid-up capital
₹1.96 Cr
Issued & subscribed
Open charges
₹10 Cr
Secured borrowings
Company age
15 yrs
Est. 2011
Employees · EPFO
4
Provident fund records

About Accredo Pharma Science Private Limited

Data last updated:

Accredo Pharma Science Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 30 December 2011 and has been in existence for over 15 years.

The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U74900TN2011PLC083825. Its GSTIN is 33AAFCR6220B1ZZ (Tamil Nadu).

The company has an authorised share capital of ₹11 Cr and a paid-up capital of ₹1.96 Cr. It is led by directors including Jain Arihant Kumar Narendrakumar (Managing Director) and Subramanian Murali (Whole-Time Director).

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Chennai, Tamil Nadu.

As per the financials filed for FY 2025, the company reported a revenue of ₹43.12 Cr, a growth of 6% compared to the previous year. For the same year it recorded a net profit of ₹1.44 Cr (net margin 3.3%) and EBITDA of ₹4.43 Cr (EBITDA margin 10.3%). Revenue has grown at a compounded annual rate (CAGR) of 14% over three years and 32% over five years.

The company has about 4 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹10 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website rsplindia.co.in.

Company details

CIN U74900TN2011PLC083825
Registration Number 083825
Incorporation Date 30 December 2011
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant

CIN history

Accredo Pharma Science has one previous CIN (Corporate Identification Number): U74900TN2011PTC083825. The current CIN is U74900TN2011PLC083825, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U74900TN2011PLC083825Current
U74900TN2011PTC083825Previous

Contact details

Accredo Pharma Science Private Limited's registered office is in Chennai, Tamil Nadu.

  • Registered Address
    New No. 14 Old No. 25/1, J Block, Chennai, Tamil Nadu, India – 600102
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Accredo Pharma Science Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Accredo Pharma Science is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Accredo Pharma Science Private Limited, buy the company report.

Financials of Accredo Pharma Science Private Limited

FY 2024 filings available

Accredo Pharma Science Private Limited reported revenue of ₹43.12 Cr (up 6% YoY) for FY 2025.

Revenue · FY 2025
₹43.12 Cr ▲ 6%
Net profit · FY 2025
₹1.44 Cr margin 3.3%
EBITDA · FY 2025
₹4.43 Cr margin 10.3%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 6%
3 years · compounded
▲ 14%
5 years · compounded
▲ 32%
EBITDA CAGR growth
1 year
▲ 82%
3 years · compounded
▲ 47%
5 years · compounded
▲ 82%

Revenue has grown at a compounded annual rate (CAGR) of 32% over five years, including 6% growth in the latest year. EBITDA rose 82% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹4.43 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹1.44 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin10.3%
Net Profit Margin3.3%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Accredo Pharma Science Private Limited, buy the company report.

Board of directors of Accredo Pharma Science Private Limited

Accredo Pharma Science has 7 current directors and 10 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Chittibabu SarathchandranAdditional Director08 May 201511 Years 5 MonthsCurrent
Jain Arihant Kumar NarendrakumarManaging Director08 May 201511 Years 5 MonthsCurrent
Subramanian MuraliWhole-Time Director11 Oct 20215 Years 0 MonthsCurrent
Siroya RajeshkumarDirector27 Mar 20188 Years 6 MonthsCurrent
Soniya JainAdditional Director16 Apr 20251 Years 6 MonthsCurrent
Anil SharmaAdditional Director20 Nov 20250 Years 11 MonthsCurrent
Showing 6 of 7 current directors. View all directors

Peer comparison

Accredo Pharma Science Private Limited is compared with the 4 companies closest to it by revenue in the Ecommerce and Internet industry (Healthcare Products), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Re'equil India Private Limited₹45.3 Cr (FY 2025)22.0%Panchkula, Haryana, India
Claris Distribution Private Limited₹44.44 Cr (FY 2025)235.0%Mumbai, Maharashtra, India
Accredo Pharma Science Private Limitedthis company₹43.12 Cr (FY 2025)₹1.44 Cr3.3%6.0%Chennai, Tamil Nadu, India
Kosmochem Private Limited₹42.93 Cr (FY 2025)6.0%Mumbai, Maharashtra, India
Medkart Pharmacy Private Limited₹41.58 Cr (FY 2024)16.0%Ahmedabad, Gujarat, India

To see the full peer comparison of Accredo Pharma Science Private Limited, buy the company report.

Charges & borrowings

Open charges
₹10 Cr
Satisfied charges
None
Breakdown by lending institutions
Others₹10.00 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
01 Feb 2021100436450Others₹10 CrOpen

To see the full charge records of Accredo Pharma Science Private Limited, buy the company report.

Total charge records: 1 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Accredo Pharma Science Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Accredo Pharma Science has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
33AAFCR6220B1ZZTamil NaduActive01 Jul 2017

To see the full GST registrations and return filing status of Accredo Pharma Science Private Limited, buy the company report.

Recent activity

Accredo Pharma Science Private Limited has 17 board changes on record since 2014: 7 appointments and 10 cessations. The latest: Anil Sharma was appointed as Additional Director on 20 Nov 2025.

Appointed
Anil Sharma was appointed as Additional Director.
Appointed
Meenakshisundaram Kolandaivel was appointed as Additional Director.
Charges
A charge with Others of Rs. 10.00 Cr registered on 01 Feb 2021 with Charge ID 100436450 was modified on 25 Aug 2025.
Ceased
Soniya Jain ceased to be Additional Director.
Appointed
Soniya Jain was appointed as Additional Director.
AGM
Accredo Pharma Science Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Accredo Pharma Science Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai.
Ceased
Jain Arihant Kumar Narendrakumar ceased to be Additional Director.
Ceased
Subramanian Murali ceased to be Additional Director.
Ceased
Bhargava ceased to be Director.
Appointed
Subramanian Murali was appointed as Whole-Time Director.
Charges
A charge with Others amounted to Rs. 10.00 Cr with Charge ID 100436450 was registered on 01 Feb 2021.

10 earlier events are in the company report.

Frequently asked questions

Accredo Pharma Science is an active private limited company based in Chennai, Tamil Nadu, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 30 December 2011 (15+ years old) and is registered under CIN U74900TN2011PLC083825.

Accredo Pharma Science has 7 current directors:

The latest financial statements of Accredo Pharma Science on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.

The GSTIN of Accredo Pharma Science is 33AAFCR6220B1ZZ, registered in Tamil Nadu.

The CIN (Corporate Identification Number) of Accredo Pharma Science is U74900TN2011PLC083825. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Accredo Pharma Science was incorporated on 30 December 2011, making it 15+ years old. It is registered with the Registrar of Companies, Chennai.

The peers of Accredo Pharma Science by revenue are Re'equil India Private Limited, Claris Distribution Private Limited, Kosmochem Private Limited, Medkart Pharmacy Private Limited, all in the Ecommerce and Internet industry (Healthcare Products), with the same principal business activity (wholesale trading).

Anil Sharma was appointed as Additional Director on 20 Nov 2025. Meenakshisundaram Kolandaivel was appointed as Additional Director on 20 Nov 2025. Soniya Jain ceased to be Additional Director on 06 Jul 2025. Accredo Pharma Science has 17 board changes on record in total.

Accredo Pharma Science can be reached through the website rsplindia.co.in. Its registered office is in Chennai, Tamil Nadu, India.

The registered office of Accredo Pharma Science is at New No. 14 Old No. 251, J Block, Chennai, Tamil Nadu, India – 600102.

Accredo Pharma Science operates in the pharma industry, in the pharmaceutical retailers and distributors segment.